According to advice published in the Netherlands last week, climate change is increasing the risk of not just infectious diseases but also cancer and heat stress. This concern has implications not just in the U.S. but globally as well.
As the risk of infectious diseases transmitted by vectors such as mosquitoes and ticks increases, experts emphasize the need to expand access to diagnostic services outside centralized labs and into homes and other field conditions. Rapid diagnosis and treatment are crucial to prevent further spread of outbreaks, and firms like Co-Diagnostics Inc. (NASDAQ: CODX) are focused on developing solutions for decentralized testing.
The warning comes from a growing body of evidence linking climate change to health threats. Rising temperatures and changing precipitation patterns are expanding the geographic range of disease-carrying vectors, exposing new populations to illnesses such as Lyme disease, dengue fever, and malaria. Additionally, heat waves are becoming more frequent and severe, leading to heat stress and exacerbating chronic conditions like cardiovascular disease. Air pollution from wildfires and fossil fuel combustion also contributes to cancer risks.
Health authorities globally are urged to invest in public health infrastructure, including surveillance systems and point-of-care diagnostics. The ability to test for infections rapidly in remote or resource-limited settings can help contain outbreaks before they become widespread. This is particularly important as climate change may lead to more frequent and intense disease emergence events.
The article was originally published on BioMedWire, a platform covering developments in biotechnology and life sciences. BioMedWire is part of the Dynamic Brand Portfolio @IBN, which provides wire solutions, editorial syndication, press release enhancement, and social media distribution to a wide audience.
